1-9 of 9
Ralph D. Sanderson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Heparanase and Chemotherapy Synergize to Drive Macrophage Activation and Enhance Tumor Growth

Udayan Bhattacharya, Lilach Gutter-Kapon, Tal Kan, Ilanit Boyango, Uri Barash, Shi-Ming Yang, JingJing Liu, Miriam Gross-Cohen, Ralph D. Sanderson, Yuval Shaked, Neta Ilan, Israel Vlodavsky
Journal: Cancer Research
Cancer Res (2020) 80 (1): 57–68.
https://doi.org/10.1158/0008-5472.CAN-19-1676
Published: 03 January 2020
View article titled, Heparanase and Chemotherapy Synergize to Drive Macrophage Activation and Enhance Tumor Growth
Open the PDF for Heparanase and Chemotherapy Synergize to Drive Macrophage Activation and Enhance Tumor Growth in another window
Includes: Supplementary data
Journal Articles

Syndecan-1 (CD138) Suppresses Apoptosis in Multiple Myeloma by Activating IGF1 Receptor: Prevention by SynstatinIGF1R Inhibits Tumor Growth

DeannaLee M. Beauvais, Oisun Jung, Yang Yang, Ralph D. Sanderson, Alan C. Rapraeger
Journal: Cancer Research
Cancer Res (2016) 76 (17): 4981–4993.
https://doi.org/10.1158/0008-5472.CAN-16-0232
Published: 31 August 2016
View article titled, Syndecan-1 (CD138) Suppresses Apoptosis in Multiple Myeloma by Activating IGF1 Receptor: Prevention by Synstatin<sub>IGF1R</sub> Inhibits Tumor Growth
Open the PDF for Syndecan-1 (CD138) Suppresses Apoptosis in Multiple Myeloma by Activating IGF1 Receptor: Prevention by Synstatin<sub>IGF1R</sub> Inhibits Tumor Growth in another window
Includes: Supplementary data
Journal Articles

Abstract 1708: Heparanase regulates response to chemotherapy in myeloma

Vishnu Prakash C. Ramani, Fenghuang Zhan, Guido Tricot, Ralph D. Sanderson
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 1708.
https://doi.org/10.1158/1538-7445.AM2014-1708
Published: 01 October 2014
View article titled, Abstract 1708: Heparanase regulates response to chemotherapy in myeloma
Journal Articles

Abstract A17: Glycosaminoglycans regulates histone acetylation status in multiple myeloma

Anurag Purushothaman, Ralph D. Sanderson
Journal: Cancer Research
Cancer Res (2013) 73 (13_Supplement): A17.
https://doi.org/10.1158/1538-7445.CEC13-A17
Published: 13 May 2014
View article titled, Abstract A17: Glycosaminoglycans regulates histone acetylation status in multiple myeloma
Journal Articles

Heparanase Enhances Local and Systemic Osteolysis in Multiple Myeloma by Upregulating the Expression and Secretion of RANKL

Yang Yang, Yongsheng Ren, Vishnu C. Ramani, Li Nan, Larry J. Suva, Ralph D. Sanderson
Journal: Cancer Research
Cancer Res (2010) 70 (21): 8329–8338.
https://doi.org/10.1158/0008-5472.CAN-10-2179
Published: 31 October 2010
View article titled, Heparanase Enhances Local and Systemic Osteolysis in Multiple Myeloma by Upregulating the Expression and Secretion of RANKL
Open the PDF for Heparanase Enhances Local and Systemic Osteolysis in Multiple Myeloma by Upregulating the Expression and Secretion of RANKL in another window
Includes: Supplementary data
Journal Articles

Expression of Heparanase by Primary Breast Tumors Promotes Bone Resorption in the Absence of Detectable Bone Metastases

Thomas Kelly, Larry J. Suva, Yan Huang, Veronica MacLeod, Hua-Quan Miao, Ronald C. Walker, Ralph D. Sanderson
Journal: Cancer Research
Cancer Res (2005) 65 (13): 5778–5784.
https://doi.org/10.1158/0008-5472.CAN-05-0749
Published: 01 July 2005
View article titled, Expression of Heparanase by Primary Breast Tumors Promotes Bone Resorption in the Absence of Detectable Bone Metastases
Open the PDF for Expression of Heparanase by Primary Breast Tumors Promotes Bone Resorption in the Absence of Detectable Bone Metastases in another window
Journal Articles

Heparanase degrades syndecan-1 and perlecan heparan sulfate: Functional implications for tumor cell invasion.

Dario Marchetti, Ralph D. Sanderson, Steven A. Barker, Marian Waguespack, Robert Long, Daniel D. Carson, Jane Reiland
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 530–531.
Published: 01 April 2004
View article titled, Heparanase degrades syndecan-1 and perlecan heparan sulfate: Functional implications for tumor cell invasion.
Journal Articles

High Heparanase Activity in Multiple Myeloma Is Associated with Elevated Microvessel Density

Thomas Kelly, Hua-Quan Miao, Yang Yang, Elizabeth Navarro, Paul Kussie, Yan Huang, Veronica MacLeod, Jonathan Casciano, Lija Joseph, Fenghuang Zhan, Maurizio Zangari, Bart Barlogie, John Shaughnessy, Ralph D. Sanderson
Journal: Cancer Research
Cancer Res (2003) 63 (24): 8749–8756.
Published: 24 December 2003
View article titled, High Heparanase Activity in Multiple Myeloma Is Associated with Elevated Microvessel Density
Open the PDF for High Heparanase Activity in Multiple Myeloma Is Associated with Elevated Microvessel Density in another window
Journal Articles

Neoglycans, Carbodiimide-modified Glycosaminoglycans: A New Class of Anticancer Agents That Inhibit Cancer Cell Proliferation and Induce Apoptosis

Carla Y. Pumphrey, Allison M. Theus, Shulin Li, Rudolph S. Parrish, Ralph D. Sanderson
Journal: Cancer Research
Cancer Res (2002) 62 (13): 3722–3728.
Published: 01 July 2002
View article titled, Neoglycans, Carbodiimide-modified Glycosaminoglycans: <subtitle>A New Class of Anticancer Agents That Inhibit Cancer Cell Proliferation and Induce Apoptosis</subtitle>
Open the PDF for Neoglycans, Carbodiimide-modified Glycosaminoglycans: <subtitle>A New Class of Anticancer Agents That Inhibit Cancer Cell Proliferation and Induce Apoptosis</subtitle> in another window